The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology.

The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology. Abstract Text:

M S Krathen,J Dunham,E Gaines,J Junkins-Hopkins,E Kim,S L Kolasinski,C Kovarik,J Kwan-Morley,J Okawa,K Propert,N Rogers,M Rose,P Thomas,A B Troxel,A Van Voorhees,J Von Feldt,A L Weber,V P Werth,

OBJECTIVE: To evaluate the validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) for use by rheumatologists via reliability testing, and to extend the validation for dermatologists. METHODS: Fourteen subjects with cutaneous lupus erythematosus (CLE; n = 10), a mimicker skin disease only (a cutaneous lesion that may appear clinically similar to CLE; n = 1), or both (n = 3) were rated with the CLASI by academic-based dermatologists (n = 5) and rheumatologists (n = 5). RESULTS: The dermatology intraclass correlation coefficient (ICC) was 0.92 for activity and 0.82 for damage; for rheumatology the ICC was 0.83 for activity and 0.86 for damage. For intrarater reliability, the dermatology Spearman's rho was 0.94 for activity and 0.97 for damage; for rheumatology the Spearman's rho was 0.91 for activity and 0.99 for damage. CONCLUSION: Our data confirm the reliability of the CLASI when used by dermatologists and support the CLASI as a reliable instrument for use by rheumatologists.

The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology. Publishing Authors By Initials

MS Krathen,J Dunham,E Gaines,J Junkins-Hopkins,E Kim,SL Kolasinski,C Kovarik,J Kwan-Morley,J Okawa,K Propert,N Rogers,M Rose,P Thomas,AB Troxel,A Van Voorhees,JV Feldt,AL Weber,VP Werth,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Arthritis and rheumatism

VOLUME: 59

Page Numbers: 338-44

Journal Abbreviation: Arthritis Rheum.

ISSN: 0004-3591

DAY: 15

MONTH: Mar

YEAR: 2008

The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370605

The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology.

AFFILIATION: University of Pennsylvania School of Medicine, Philadelphia.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arthritis Rheum

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology Related Publications

• Activation of autoimmunity following use of immunostimulatory herbal supplements.
• CONTINUING EDUCATION: Is It Valid?
• Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
• Cutaneous lupus: insights into pathogenesis and disease classification.
• Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
• Dermatologic therapeutics: thalidomide. A practical guide.
• Dermatology vignette. Pseudoporphyria caused by NSAIDs.
• Development of outcome measures for autoimmune dermatoses.
• Failure of physiologic doses of pure UVA or UVB to induce lesions in photosensitive cutaneous lupus erythematosus: implications for phototesting.
• Lizard ecology: evidence of competition.
• Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center.
• Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion.
• Pathophysiology of cutaneous lupus erythematosus.
• RISK MANAGEMENT FOR CHIROPRACTORS AND OSTEOPATHS: Neck Manipulation & Vertebrobasilar Stroke.
• Regeneration of sulfur-fouled bimetallic Pd-based catalysts.
• Reliability of fMRI during a Continuous Motor Task: Assessment of Analysis Techniques.
• Risk Management for Chiropractors and Osteopaths. Informed consent: A Common Law Requirement.
• Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions.
• The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology.
• The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.
• Treatment of bullous pemphigoid with topical corticosteroids: review of a randomized controlled trial.
• Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
• Ulcerating skin lesions and arthritis after a crab bite.
• What is new in the treatment of steroid-induced osteoporosis?
• What is new in the treatment of steroid-induced osteoporosis?
• [Effect of malachite green on metabolism, especially on the enzymes of the respiratory chain in rats and their relation to the problem of abnormalities and carcinogenesis.]
• [Incidence of hereditary disorders caused by prolonged malachite green poisoning in rats; a contribution to chemogenesis.]
• [Methods of experimental research on cancer and its significance in practical medicine.]
• [The effect of malachite green on the growth of Walker rat carcinoma and Ehrlich mouse ascites tumor.]
• [The history of medicine. Richard Werth (1850-1918)]